Compass Capital Management Lifted Its Cvs Health (CVS) Holding; Financial Counselors Has Upped Its Biomarin Pharmaceutical (BMRN) Stake

November 15, 2017 - By Kurt Siggers

Compass Capital Management Inc increased Cvs Health Corp (CVS) stake by 5.41% reported in 2017Q2 SEC filing. Compass Capital Management Inc acquired 15,129 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Compass Capital Management Inc holds 294,714 shares with $23.71M value, up from 279,585 last quarter. Cvs Health Corp now has $71.36 billion valuation. The stock decreased 1.40% or $1 during the last trading session, reaching $70.44. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since November 15, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Financial Counselors Inc increased Biomarin Pharmaceutical Inc (BMRN) stake by 79.45% reported in 2017Q2 SEC filing. Financial Counselors Inc acquired 5,002 shares as Biomarin Pharmaceutical Inc (BMRN)’s stock declined 0.71%. The Financial Counselors Inc holds 11,298 shares with $1.03 million value, up from 6,296 last quarter. Biomarin Pharmaceutical Inc now has $14.30B valuation. The stock increased 0.43% or $0.35 during the last trading session, reaching $81.41. About shares traded. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since November 15, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

Investors sentiment decreased to 0.92 in Q2 2017. Its down 0.17, from 1.09 in 2017Q1. It dived, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Mayo Investment Advisers Lc holds 97,763 shares. Bank Of Stockton owns 16,389 shares. Cypress Asset Mgmt Inc Tx accumulated 26,670 shares. Allstate Corporation owns 44,142 shares for 0.19% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.28% in CVS Health Corp (NYSE:CVS) or 359,746 shares. Cannell Peter B And Co Inc invested in 0.01% or 3,890 shares. Amica Mutual reported 65,868 shares stake. Susquehanna Gp Limited Liability Partnership reported 122,793 shares. California Public Employees Retirement System invested 0.32% in CVS Health Corp (NYSE:CVS). Old Dominion Cap Management Inc holds 7,900 shares. Diversified Tru Com reported 4,683 shares. Punch & Investment Mngmt Inc holds 0.42% or 55,743 shares. Iowa Natl Bank holds 0.72% of its portfolio in CVS Health Corp (NYSE:CVS) for 18,637 shares. Archford Strategies Llc reported 115 shares. The Ohio-based Boyd Watterson Asset Lc Oh has invested 0.36% in CVS Health Corp (NYSE:CVS).

Since June 12, 2017, it had 0 insider purchases, and 1 insider sale for $18.44 million activity. Denton David M sold $18.44M worth of CVS Health Corp (NYSE:CVS) on Monday, June 12.

Among 24 analysts covering CVS Health (NYSE:CVS), 15 have Buy rating, 0 Sell and 9 Hold. Therefore 63% are positive. CVS Health has $132 highest and $73 lowest target. $97.85’s average target is 38.91% above currents $70.44 stock price. CVS Health had 52 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) earned “Hold” rating by Jefferies on Wednesday, August 16. The stock of CVS Health Corp (NYSE:CVS) earned “Neutral” rating by Citigroup on Friday, November 3. Robert W. Baird initiated CVS Health Corp (NYSE:CVS) rating on Friday, January 22. Robert W. Baird has “Outperform” rating and $108 target. The firm has “Buy” rating by Evercore given on Wednesday, August 19. Vetr upgraded the stock to “Buy” rating in Monday, August 24 report. Oppenheimer maintained the stock with “Outperform” rating in Friday, August 28 report. Leerink Swann maintained it with “Outperform” rating and $85 target in Tuesday, November 7 report. The stock of CVS Health Corp (NYSE:CVS) earned “Hold” rating by Jefferies on Wednesday, October 18. The firm has “Buy” rating given on Tuesday, August 8 by Oppenheimer. The stock of CVS Health Corp (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, September 15.

Since May 17, 2017, it had 0 insider purchases, and 8 selling transactions for $5.08 million activity. BIENAIME JEAN JACQUES also sold $655,377 worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Wednesday, May 31. Shares for $1.35M were sold by FUCHS HENRY J on Friday, June 16. LAWLIS V BRYAN had sold 3,750 shares worth $337,500 on Friday, June 16. Ajer Jeffrey Robert sold 1,004 shares worth $89,968. Davis George Eric had sold 9,471 shares worth $862,230.

Among 27 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 19 have Buy rating, 0 Sell and 8 Hold. Therefore 70% are positive. BioMarin Pharmaceutical has $175 highest and $89 lowest target. $117.75’s average target is 44.64% above currents $81.41 stock price. BioMarin Pharmaceutical had 73 analyst reports since August 5, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of BMRN in report on Thursday, August 3 with “Buy” rating. The firm earned “Outperform” rating on Tuesday, February 23 by Leerink Swann. Credit Suisse initiated BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Wednesday, January 20 with “Outperform” rating. On Tuesday, July 11 the stock rating was maintained by J.P. Morgan with “Buy”. The firm has “Buy” rating given on Thursday, July 6 by BMO Capital Markets. The firm earned “Buy” rating on Thursday, August 3 by Cowen & Co. The company was initiated on Friday, October 2 by Raymond James. The rating was maintained by Credit Suisse on Thursday, October 19 with “Buy”. On Thursday, August 24 the stock rating was maintained by Jefferies with “Buy”. Robert W. Baird maintained the stock with “Buy” rating in Tuesday, October 3 report.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.06, from 1.2 in 2017Q1. It is positive, as 23 investors sold BMRN shares while 124 reduced holdings. 51 funds opened positions while 134 raised stakes. 168.09 million shares or 1.78% more from 165.15 million shares in 2017Q1 were reported. Hutchin Hill LP holds 0.17% or 55,300 shares. Sumitomo Mitsui Tru owns 545,374 shares or 0.07% of their US portfolio. Etrade Cap Management Limited Com owns 4,528 shares or 0.02% of their US portfolio. Cap One National Association, New York-based fund reported 10,579 shares. Suntrust Banks stated it has 0% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Marshall Wace Ltd Liability Partnership holds 0.05% or 13,606 shares. West Oak Ltd Liability Corporation holds 0% or 147 shares in its portfolio. Winslow Evans And Crocker, a Massachusetts-based fund reported 77 shares. Primecap Ca invested in 0.73% or 9.31M shares. Moreover, Northern Trust has 0.03% invested in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 1.10M shares. Baystate Wealth Ltd Liability accumulated 0% or 10 shares. Symphony Asset Management Ltd accumulated 6,465 shares. Comml Bank Of America Corporation De owns 2.06M shares. Grandfield & Dodd Limited Liability Com holds 0.06% or 5,847 shares in its portfolio. Aviva Public Ltd reported 106,350 shares.

Financial Counselors Inc decreased Applied Materials Inc (NASDAQ:AMAT) stake by 22,971 shares to 134,226 valued at $5.55 million in 2017Q2. It also reduced Eog Resources Inc (NYSE:EOG) stake by 3,818 shares and now owns 27,415 shares. Ishares Core S&P Small (IJR) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com